A comparison of once daily atenolol and metoprolol SA in mild to moderate hypertension
- PMID: 6347229
- PMCID: PMC1427914
- DOI: 10.1111/j.1365-2125.1983.tb01555.x
A comparison of once daily atenolol and metoprolol SA in mild to moderate hypertension
Abstract
Atenolol 100 mg once daily and metoprolol SA 200 mg once daily were compared in 20 patients with mild to moderate hypertension, in a randomised, double-blind cross-over trial. Blood pressure and heart rate were compared at rest and during maximal exercise on a bicycle ergometer at 2 and 24 h post-dose. Blood pressure control was similar with both drugs, except at 2 h when systolic blood pressure was significantly lower with atenolol. Blood pressure and heart rate were less well controlled at 24 h than at 2 h with both drugs, but the majority of patients were still considered adequately controlled at 24 h. Atenolol and metoprolol SA can be considered equally effective in the treatment of mild to moderate hypertension and can be recommended as a once daily regime.
Similar articles
-
A double-blind comparison of metoprolol CR/ZOK 50 mg and atenolol 50 mg once daily for uncomplicated hypertension.J Clin Pharmacol. 1990 Feb;30(S2):S72-7. doi: 10.1002/j.1552-4604.1990.tb03500.x. J Clin Pharmacol. 1990. PMID: 2179284 Clinical Trial.
-
A double-blind comparison of once-daily metoprolol controlled-release and atenolol in the treatment of Chinese patients with mild to moderate hypertension.Cardiovasc Drugs Ther. 1995 Jun;9(3):401-6. doi: 10.1007/BF00879028. Cardiovasc Drugs Ther. 1995. PMID: 8527349 Clinical Trial.
-
Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol.Br Med J (Clin Res Ed). 1982 Nov 13;285(6352):1387-92. doi: 10.1136/bmj.285.6352.1387. Br Med J (Clin Res Ed). 1982. PMID: 6814568 Free PMC article. Clinical Trial.
-
Controlled release metoprolol formulations. A review of their pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and ischaemic heart disease.Drugs. 1992 Mar;43(3):382-414. doi: 10.2165/00003495-199243030-00006. Drugs. 1992. PMID: 1374320 Review.
-
Treatment with beta-blockers--the value of an even plasma concentration over 24 h.J Clin Pharm Ther. 1997 Jun;22(3):171-9. doi: 10.1046/j.1365-2710.1997.8775087.x. J Clin Pharm Ther. 1997. PMID: 9447471 Review.
Cited by
-
Metoprolol: a pharmacoeconomic and quality-of-life evaluation of its use in hypertension, post-myocardial infarction and dilated cardiomyopathy.Pharmacoeconomics. 1994 Oct;6(4):370-400. doi: 10.2165/00019053-199406040-00004. Pharmacoeconomics. 1994. PMID: 10147474 Review.
-
Evidence based general practice: a retrospective study of interventions in one training practice.BMJ. 1996 Mar 30;312(7034):819-21. doi: 10.1136/bmj.312.7034.819. BMJ. 1996. PMID: 8608291 Free PMC article.
-
Metoprolol. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in hypertension, ischaemic heart disease and related cardiovascular disorders.Drugs. 1986 May;31(5):376-429. doi: 10.2165/00003495-198631050-00002. Drugs. 1986. PMID: 2940080 Review.
-
Beta-adrenoceptor blockade and exercise. An update.Sports Med. 1988 Apr;5(4):209-25. doi: 10.2165/00007256-198805040-00002. Sports Med. 1988. PMID: 2897710 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical